After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
The deal consists of a portfolio of medicines and vaccines, nutritionals and supplements for aquatic species, two aqua manufacturing facilities in Canada and Vietnam, as well as a research facility in Chile.
GSK has been trying to replenish its product pipeline as the company faces pressure to improve shareholder returns and keep up with rival AstraZeneca Plc.
April 18, 2023
Join our Membership
Join the Merger & Acquisitions community to access premium content and exclusive member-only benefits.